- Not Fee assured
- Verified this account
Dr Anna Martinez has been a consultant in Paediatric Dermatology at Great Ormond Street Hospital for Children NHS Foundation Trust and Honorary Lecturer at the Institute of Child Health, University College London since 2003
She trained at St Bartholomew’s Hospital and was appointed Consultant in Paediatric Dermatology at Great Ormond Street Hospital in January 2003.
Anna has led the Nationally Commissioned Service for Epidermolysis Bullosa and is a world leader in the management of skin fragility diseases.
Anna also leads the combined allergy/dermatology service at GOSH
Areas of interest
Clinical expertise include eczema; skin fragility disorders; vascular anomalies; the management of the inherited ichthyoses; Netherton syndrome; clinical management of skin fragility disorders; clinical research
Current NHS consultant posts held
Consultant in Paediatric Dermatology at Great Ormond Street Hospital for Children NHS Foundation Trust
Research includes Principal Investigator and co-investigator running
5 current clinical trials. Awarded NIHR National Principal Investigator 2016/2017 for contributions to research
Dr Martinez’ special clinical interests are skin fragility disorders, difficult eczema; vascular anomalies and genetic disorders of the skin, in particular the inherited ichthyoses and Netherton syndrome which she manages at GOSH
Clinical Excellence Awards in 2011 & 2013 and 2017
45 peer reviewed publications - examples
The RCPCH care pathway for food allergy in children: An evidence and consensus based na-tional approach
Fox, A.T., Lloyd, K., Arkwright, P.D., Bhattacharya, D., Brown, T., Chetcuti, P., East, M., Gaventa, J., King, R., Martinez, A., Meyer, R, J.
Archives of Disease in Childhood
volume 96, issue 2, year 2011
A consensus approach to wound care in epidermolysis bullosa. Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R, U, Sibbald G. J Am Acad Dermatol 2012,
The safety of oral Azathioprine in Paediatric atopic dermatitis – guidelines for monitoring Nicholas R Fuggle Walter Bragoli (BSc), Anjali Mahto (MD), Anna E Martinez, Veronica A Kinsler . . J Am Acad Dermatol. 2015 Jan;72(1):108-14
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman Mf, Leigh I, Marinkovich MP, Martinez AM, McGrath JA, Mellerio JE, Zambruno G. J Am Acad Dermatol 2014; 70: 1103-26.
New vascular classification of port-wine stains: improving prediction of Sturge-Webe risk.
Waelchli R, Aylett SE, Robinson K, Chong WK, Martinez AE, Kinsler VA.
Br J Dermatol. 2014 Oct;171(4):861-7. dos: 10.1111/bjd.13203 2014 Oct 1
Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.
Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE, Slaper-Cortenbach I, Boelens JJ, Tolar J, Veys P, Ofuya M, Peacock JL, Martinez AE, McGrath JA.
J Invest Dermatol. 2015; 135:2319-21
Management of cutaneous suampous cell carcinoma in patients with epidermolysis bullosa- best clinical practice guidelines. Mellerio JE, Roberston SJ, Bernardis c, Diem A, Fine JD, Goldberg D, Halmos GB, Harries M, Jonkman MF, Lucky A, Martinez AE,JC, McGrath JA. Br J Dermatol 2015 ( Epub ahead of print)
The p.Glu477Lys mutation in keratin 5 is strongly associated with mortality in generalized severe epidermolysis bullosa simplex.
Sathishkumar D et al J Invest Dermatol. 2015 Dec
Mesenchymal stem cell transplant for recessive dystrophic epidermolysis bullosa: prospects and clinical progress E. Rashidghamat1, J. E. Mellerio1,2 , A. E. Martinez2, J. A. McGrath1 Expert Opinion on Orphan Drugs 2016
Courses offered to GPs
Update in paediatric dermatology
Blistering in children
Blistering in neonates
- MBBS MRCH FRCPCH St Bartholomews Hospital 1991
- Paediatric Dermatology North London 1996
Reference number 3489189
Affiliations / memberships
RCPCH National Guidelines Working Group for food allergy 2009 -11
External Advisory Panel cell therapy trails Netherlands 2012-date
International Consensus Committee Classification EB 2013 on going
Medical Advisor Board Ichthyosis Support Group 2013 on going
Scientific Advisory Board of DEBRA America 2013 on going
European Society for Dermatological Research
- 215 The Portland Hospital
- 08:30 - 15:00
- 020 7390 8020
- 234 The Portland Hospital
- 09:00 - 13:00
- 020 7390 8020
- 234 The Portland Hospital, W1W 5AH
- 09:00 - 14:00
- 020 7390 8020
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.